(02) Guidelines

Standards every SciVue creator follows.

Read these before you apply. They mirror the expectations researchers already have from leading scientific-illustration platforms — quality, originality, scientific accuracy, clean editable artwork.

Four pillars

Scientific accuracy

Every label, ratio, pathway direction and structural detail must be defensible against current peer-reviewed literature. Cite a primary source for any non-textbook claim.

Originality

Templates must be authored by you. Tracing, AI-generated illustration without substantial human editing, or recompositions of another artist's figure are not accepted.

Visual consistency

Use the SciVue palette tokens and the Sora / Manrope type pair. Stroke widths, corner radii and arrow heads should match the editor's primitives so users can recolor and edit cleanly.

Editable, not flattened

Ship native canvas items (shapes, text, groups) — not embedded raster screenshots. Every group should be selectable, recolorable, and replaceable inside the studio.

Do

  • Build at 1:1 print scale; keep titles ≥ 22 pt and body text ≥ 11 pt
  • Group logically (one organelle = one group; one pathway step = one group)
  • Name every layer so reviewers and end-users can navigate the document
  • Use semantic palette tokens (cancerFill, membraneLipid, …) — never hard-coded hex
  • Provide a one-line blurb and 3–6 tags so the gallery surfaces your work
  • Include alternative text on diagrams that convey content

Don't

  • Don't submit work derived from copyrighted figures (journal art, textbook plates, BioRender exports, competitor templates)
  • Don't include logos, brand marks, patient photos, or recognisable faces
  • Don't bake captions into rasters — captions must remain editable text
  • Don't use stock-photo gradients, lens flares, or 3-D bevels — keep the SciVue clean style
  • Don't bundle external fonts; rely on the platform's licensed type pair
  • Don't claim clinical advice or diagnostic use; templates are for science communication only

What we publish

SciVue is a scientific-illustration platform. Submissions outside this scope are returned without review.

Accepted
  • Pathway diagrams, cell schematics, anatomical cross-sections
  • Lab protocols and workflow timelines
  • Multi-panel results figures (concept-level, not real patient data)
  • Conference poster layouts and slide decks
  • Icon packs of related objects (proteins, lab equipment, organisms)
Not accepted
  • Single-icon submissions — bundle related icons into a pack of ≥ 8
  • Marketing material, infographics for non-scientific audiences
  • Religious, political or culturally insensitive imagery
  • Anything that contains personally identifiable health information

Intellectual property

You retain copyright on everything you publish. By accepting a template into the marketplace, you grant SciVue a non-exclusive, worldwide licence to host, display, and let end-users edit and export your work as part of their figures. End-user exports are licensed for use in publications, posters and presentations with attribution to SciVue.

Revenue & payouts

Creators receive 70% of net revenue attributed to their templates and icon packs. Payouts are monthly via Stripe or bank transfer once you cross the $50 threshold. Detailed analytics are available in your contributor dashboard.

Review process

01

Submit

Apply via the form below. You'll need an ORCID iD or a portfolio link.

02

Triage (24 h)

Editorial team checks fit, originality, and that the application is complete.

03

Review (48 h)

A subject-matter reviewer scores scientific accuracy and visual quality.

04

Onboarding

Approved creators get a contributor dashboard, style kit, and the publishing checklist.

05

Publishing

Each template ships through the same review pipeline. Most decisions in 3–5 business days.

Violations & enforcement

Templates flagged for copyright infringement, scientific inaccuracy, or breaches of these guidelines are unpublished pending review. Repeated or egregious violations result in removal from the creator programme and forfeiture of pending payouts. We comply with all valid DMCA takedown notices — see our Trust & Safety page for the process.

Last updated: June 2026. We may revise these guidelines; material changes are emailed to active creators 30 days before they take effect.

Ready to apply?

Confirm you've read these guidelines on the application form.